Hippocratic AI, a leader in healthcare-focused large language models (LLMs), announced the successful completion of its $141 million Series B financing round, bringing its valuation to $1.64 billion. Led by Kleiner Perkins and supported by notable investors like A16z, NVIDIA, and General Catalyst, the funding will support the company’s mission to improve global healthcare accessibility and outcomes. Hippocratic AI’s Polaris constellation LLM architecture has achieved clinical safety parity with human clinicians and gained traction with 23 healthcare organizations, including UHS, WellSpan Health, and Cincinnati Children’s, delivering outstanding patient interactions rated an average of 8.7 out of 10. The company plans to expand its solutions into new verticals like pharma and payors while entering markets in EMEA, Southeast Asia, and Latin America.
CEO Munjal Shah highlighted Hippocratic AI’s rapid progress, including the release of the Polaris 2.0 architecture with 3.7 trillion parameters, securing its first U.S. patent, and launching an AI Agent App Store to allow licensed clinicians to design specialized AI agents. With strong partnerships from founding health systems and a commitment to patient safety, Hippocratic AI is positioned to address healthcare staffing shortages and transform healthcare delivery through generative AI. Investors like Kleiner Perkins view the company as pioneering a new category, estimating the potential market for generative AI in healthcare to be 10 times the size of the healthcare software market alone.
Read the full article here